Inventory of non-ataxia signs (INAS): Validation of a new clinical assessment instrument

H. Jacobi, M. Rakowicz, R. Rola, R. Fancellu, C. Mariotti, P. Charles, A. Dürr, M. Küper, D. Timmann, C. Linnemann, L. Schöls, O. Kaut, C. Schaub, A. Filla, L. Balikó, B. Melegh, J. S. Kang, P. Giunti, B. P C Van De Warrenburg, R. FimmersT. Klockgether

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Although ataxia is by definition the prominent symptom of ataxia disorders, there are various neurological signs that may accompany ataxia in affected patients. Reliable and quantitative assessment of these signs is important because they contribute to disability, but may also interfere with ataxia. Therefore we devised the Inventory of Non-Ataxia Signs (INAS), a list of neurological signs that allows determining the presence and severity of non-ataxia signs in a standardized way. INAS underwent a rigorous validation procedure that involved a trial of 140 patients with spinocerebellar ataxia (SCA) for testing of inter-rater reliability and another trial of 28 SCA patients to assess short-term intra-rater reliability. In addition, data of the ongoing EUROSCA natural history study were used to determine the reproducibility, responsiveness and validity of INAS. Inter-rater reliability and short-term test-retest reliability was high, both for the total count and for most of the items. However, measures of responsiveness, such as the smallest detectable change and the clinically important change were not satisfactory. In addition, INAS did not differentiate between subjects that were subjectively stable and those that worsened in the 2-year observation period. In summary, INAS and INAS count showed good reproducibility, but unsatisfactory responsiveness. The present analysis and published data from the EUROSCA natural history study suggest that INAS is a valid measure of extracerebellar involvement in progressive ataxia disorders. As such, it is useful as a supplement to the measures of ataxia, but not as a primary outcome measure in future interventional trials.

Original languageEnglish
Pages (from-to)418-428
Number of pages11
JournalCerebellum
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Ataxia
Equipment and Supplies
Natural History
Spinocerebellar Ataxias
Nervous System Diseases
Reproducibility of Results
Observation
Outcome Assessment (Health Care)

Keywords

  • Ataxia
  • Non-ataxia signs
  • Scales
  • Validation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Jacobi, H., Rakowicz, M., Rola, R., Fancellu, R., Mariotti, C., Charles, P., ... Klockgether, T. (2013). Inventory of non-ataxia signs (INAS): Validation of a new clinical assessment instrument. Cerebellum, 12(3), 418-428. https://doi.org/10.1007/s12311-012-0421-3

Inventory of non-ataxia signs (INAS) : Validation of a new clinical assessment instrument. / Jacobi, H.; Rakowicz, M.; Rola, R.; Fancellu, R.; Mariotti, C.; Charles, P.; Dürr, A.; Küper, M.; Timmann, D.; Linnemann, C.; Schöls, L.; Kaut, O.; Schaub, C.; Filla, A.; Balikó, L.; Melegh, B.; Kang, J. S.; Giunti, P.; Van De Warrenburg, B. P C; Fimmers, R.; Klockgether, T.

In: Cerebellum, Vol. 12, No. 3, 06.2013, p. 418-428.

Research output: Contribution to journalArticle

Jacobi, H, Rakowicz, M, Rola, R, Fancellu, R, Mariotti, C, Charles, P, Dürr, A, Küper, M, Timmann, D, Linnemann, C, Schöls, L, Kaut, O, Schaub, C, Filla, A, Balikó, L, Melegh, B, Kang, JS, Giunti, P, Van De Warrenburg, BPC, Fimmers, R & Klockgether, T 2013, 'Inventory of non-ataxia signs (INAS): Validation of a new clinical assessment instrument', Cerebellum, vol. 12, no. 3, pp. 418-428. https://doi.org/10.1007/s12311-012-0421-3
Jacobi H, Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P et al. Inventory of non-ataxia signs (INAS): Validation of a new clinical assessment instrument. Cerebellum. 2013 Jun;12(3):418-428. https://doi.org/10.1007/s12311-012-0421-3
Jacobi, H. ; Rakowicz, M. ; Rola, R. ; Fancellu, R. ; Mariotti, C. ; Charles, P. ; Dürr, A. ; Küper, M. ; Timmann, D. ; Linnemann, C. ; Schöls, L. ; Kaut, O. ; Schaub, C. ; Filla, A. ; Balikó, L. ; Melegh, B. ; Kang, J. S. ; Giunti, P. ; Van De Warrenburg, B. P C ; Fimmers, R. ; Klockgether, T. / Inventory of non-ataxia signs (INAS) : Validation of a new clinical assessment instrument. In: Cerebellum. 2013 ; Vol. 12, No. 3. pp. 418-428.
@article{e16a52817af84c10a517ff31ce47f034,
title = "Inventory of non-ataxia signs (INAS): Validation of a new clinical assessment instrument",
abstract = "Although ataxia is by definition the prominent symptom of ataxia disorders, there are various neurological signs that may accompany ataxia in affected patients. Reliable and quantitative assessment of these signs is important because they contribute to disability, but may also interfere with ataxia. Therefore we devised the Inventory of Non-Ataxia Signs (INAS), a list of neurological signs that allows determining the presence and severity of non-ataxia signs in a standardized way. INAS underwent a rigorous validation procedure that involved a trial of 140 patients with spinocerebellar ataxia (SCA) for testing of inter-rater reliability and another trial of 28 SCA patients to assess short-term intra-rater reliability. In addition, data of the ongoing EUROSCA natural history study were used to determine the reproducibility, responsiveness and validity of INAS. Inter-rater reliability and short-term test-retest reliability was high, both for the total count and for most of the items. However, measures of responsiveness, such as the smallest detectable change and the clinically important change were not satisfactory. In addition, INAS did not differentiate between subjects that were subjectively stable and those that worsened in the 2-year observation period. In summary, INAS and INAS count showed good reproducibility, but unsatisfactory responsiveness. The present analysis and published data from the EUROSCA natural history study suggest that INAS is a valid measure of extracerebellar involvement in progressive ataxia disorders. As such, it is useful as a supplement to the measures of ataxia, but not as a primary outcome measure in future interventional trials.",
keywords = "Ataxia, Non-ataxia signs, Scales, Validation",
author = "H. Jacobi and M. Rakowicz and R. Rola and R. Fancellu and C. Mariotti and P. Charles and A. D{\"u}rr and M. K{\"u}per and D. Timmann and C. Linnemann and L. Sch{\"o}ls and O. Kaut and C. Schaub and A. Filla and L. Balik{\'o} and B. Melegh and Kang, {J. S.} and P. Giunti and {Van De Warrenburg}, {B. P C} and R. Fimmers and T. Klockgether",
year = "2013",
month = "6",
doi = "10.1007/s12311-012-0421-3",
language = "English",
volume = "12",
pages = "418--428",
journal = "Cerebellum",
issn = "1473-4222",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Inventory of non-ataxia signs (INAS)

T2 - Validation of a new clinical assessment instrument

AU - Jacobi, H.

AU - Rakowicz, M.

AU - Rola, R.

AU - Fancellu, R.

AU - Mariotti, C.

AU - Charles, P.

AU - Dürr, A.

AU - Küper, M.

AU - Timmann, D.

AU - Linnemann, C.

AU - Schöls, L.

AU - Kaut, O.

AU - Schaub, C.

AU - Filla, A.

AU - Balikó, L.

AU - Melegh, B.

AU - Kang, J. S.

AU - Giunti, P.

AU - Van De Warrenburg, B. P C

AU - Fimmers, R.

AU - Klockgether, T.

PY - 2013/6

Y1 - 2013/6

N2 - Although ataxia is by definition the prominent symptom of ataxia disorders, there are various neurological signs that may accompany ataxia in affected patients. Reliable and quantitative assessment of these signs is important because they contribute to disability, but may also interfere with ataxia. Therefore we devised the Inventory of Non-Ataxia Signs (INAS), a list of neurological signs that allows determining the presence and severity of non-ataxia signs in a standardized way. INAS underwent a rigorous validation procedure that involved a trial of 140 patients with spinocerebellar ataxia (SCA) for testing of inter-rater reliability and another trial of 28 SCA patients to assess short-term intra-rater reliability. In addition, data of the ongoing EUROSCA natural history study were used to determine the reproducibility, responsiveness and validity of INAS. Inter-rater reliability and short-term test-retest reliability was high, both for the total count and for most of the items. However, measures of responsiveness, such as the smallest detectable change and the clinically important change were not satisfactory. In addition, INAS did not differentiate between subjects that were subjectively stable and those that worsened in the 2-year observation period. In summary, INAS and INAS count showed good reproducibility, but unsatisfactory responsiveness. The present analysis and published data from the EUROSCA natural history study suggest that INAS is a valid measure of extracerebellar involvement in progressive ataxia disorders. As such, it is useful as a supplement to the measures of ataxia, but not as a primary outcome measure in future interventional trials.

AB - Although ataxia is by definition the prominent symptom of ataxia disorders, there are various neurological signs that may accompany ataxia in affected patients. Reliable and quantitative assessment of these signs is important because they contribute to disability, but may also interfere with ataxia. Therefore we devised the Inventory of Non-Ataxia Signs (INAS), a list of neurological signs that allows determining the presence and severity of non-ataxia signs in a standardized way. INAS underwent a rigorous validation procedure that involved a trial of 140 patients with spinocerebellar ataxia (SCA) for testing of inter-rater reliability and another trial of 28 SCA patients to assess short-term intra-rater reliability. In addition, data of the ongoing EUROSCA natural history study were used to determine the reproducibility, responsiveness and validity of INAS. Inter-rater reliability and short-term test-retest reliability was high, both for the total count and for most of the items. However, measures of responsiveness, such as the smallest detectable change and the clinically important change were not satisfactory. In addition, INAS did not differentiate between subjects that were subjectively stable and those that worsened in the 2-year observation period. In summary, INAS and INAS count showed good reproducibility, but unsatisfactory responsiveness. The present analysis and published data from the EUROSCA natural history study suggest that INAS is a valid measure of extracerebellar involvement in progressive ataxia disorders. As such, it is useful as a supplement to the measures of ataxia, but not as a primary outcome measure in future interventional trials.

KW - Ataxia

KW - Non-ataxia signs

KW - Scales

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=84879027170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879027170&partnerID=8YFLogxK

U2 - 10.1007/s12311-012-0421-3

DO - 10.1007/s12311-012-0421-3

M3 - Article

C2 - 23090211

AN - SCOPUS:84879027170

VL - 12

SP - 418

EP - 428

JO - Cerebellum

JF - Cerebellum

SN - 1473-4222

IS - 3

ER -